Skip to main content
. Author manuscript; available in PMC: 2009 Nov 13.
Published in final edited form as: J Med Chem. 2008 Oct 8;51(21):6650–6653. doi: 10.1021/jm800979v

Figure 2.

Figure 2

Antitumor activity in MDA-MB231 human breast cancer xenograft-bearing C.B-17 SCID female mice (n = 10 animals per group) treated with 20 mg/kg iv q7dx3 6-epi-dictyostatin 1 (○) or paclitaxel (△), vehicle (▲), or no treatment (▽). Arrows inidicate the days of dosing.